ArticleQuantitative imaging in medicine and surgery2025
An interpretable machine learning model for predicting visceral pleural invasion in cT1 lung adenocarcinoma based on habitat analysis.
Article in Quantitative imaging in medicine and surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Assessment of prognostic stratification in colorectal cancer liver metastases using preoperative CT habitat imaging.Frontiers in oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Visceral pleural invasion (VPI) is a critical prognostic factor in early-stage lung adenocarcinoma, influencing T staging and treatment decisions, yet its preoperative assessment remains challenging due to reliance on postoperative pathological confirmation. This study evaluates interpretable machine learning models to predict VPI in solid cT1 pulmonary nodules using preoperative computed tomography (CT)-based habitat analysis, offering a non-invasive tool to optimize surgical planning. Methods: This retrospective study analyzed data of 802 patient with invasive pulmonary adenocarcinoma and solid lung nodules ≤3 cm from two centers and a public database. CT scans were preprocessed and regions were delineated for feature extraction. Habitat analysis using K-means clustering identified tumor heterogeneity. Radiomic features were extracted and modeled using light gradient boosting machine (LightGBM), with interpretability via SHapley Additive exPlanations (SHAP). Statistical analyses included logistic regression for predictive modeling, Kaplan-Meier for survival assessment, and evaluation of area under the curve (AUC), calibration, and decision curve analysis (DCA) for model performance. Results: The intra-tumoral region and the P5 region, which encompasses both the tumor and peri-tumor areas, were analyzed for habitat characterization. K-means unsupervised clustering was employed to generate habitat subregions. From each subregion, 1,834 radiomic features were extracted. The P5-model, demonstrated superior VPI prediction with an AUC of 0.787 [95% confidence interval (CI): 0.728-0.846] in the external test cohort (ETC), significantly outperforming intra-model (P=0.008). Calibration curves confirmed prediction consistency, and DCA showed a higher net benefit across thresholds. Kaplan-Meier survival analysis stratified patients into high- and low-risk groups effectively (P=0.042). SHAP analysis highlighted the significant role of peritumoral features, providing both global and local interpretability. Conclusions: The model demonstrates robust predictive accuracy for VPI status and effective prognosis stratification in cT1 stage lung adenocarcinoma patients, providing a non-invasive technique that significantly aids surgeons in preoperative planning and enhances clinical decision-making and patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.